## Note
nid: 1557495018202
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3), #AK_Step2_v11::!Shelf::#Cards_AnKing_Did::5psych, #AK_Step2_v11::!Shelf::Psych::no_dupes, #AK_Step2_v11::!Shelf::Psych::no_dupes::only_step2, #AK_Step2_v11::#AMBOSS::PSYCH, #AK_Step2_v11::#B&B::04_Neuro::03_Movement_Disorders::01_Parkinson's_Disease, #AK_Step2_v11::#NBME, #AK_Step2_v11::#OME::10_Neurology::03_Tremor, #AK_Step2_v11::#OME_banner::Clinical::10_Neurology::03_Tremor, #AK_Step2_v11::#Resources_by_rotation::Psych::uworld::dorian, #AK_Step2_v11::#Subjects::Neurology::11_Degenerative_Disorders::Parkinson_Disease, #AK_Step2_v11::#Subjects::Neurology::11_Degenerative_Disorders::Parkinson_Disease::Management, #AK_Step2_v11::Original_decks::Dorian::psych::uw
markdown: false

### Text
Are <u>dopamine agonists</u> or <u>carbidopa-levodopa</u>
associated with a <i>higher</i> risk of <b>psychosis</b>?
<div>
  {{c1::Dopamine agonists (pramipexole, ropinirole)}}
</div>

### Extra
<div>
  <div style="font-style: italic; font-weight: bold;">
  </div><i>Reduce the dose of the dopamine agonist, but can add
  a</i> <u>low<span style="font-weight: bold">-</span>potency
  antipsychotic</u> <i>if psychotic symptoms continue (e.g.</i>
  <b style="font-style: italic;">quetiapine</b><span style=
  "font-style: italic;">,</span> <b style=
  "font-style: italic;">pimavanserin</b><i>) - high potency (e.g.
  haldol) will block D<sub>2</sub> receptors more → ↑
  extrapyramidal symptoms of Parkinson's disease</i>
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/neurology/tremor/acquire?ref=anki"><img src="_OME_AnkiFlashcards_Lesson_1.png"></a>
</div>

### Additional Resources


### One by one

